
    
      Patients with ventricular tachycardia of unknown origin and treated with an implantable
      cardioverter-defibrillator (ICD) will be asked to participate in the study. For patients with
      results showing mutations in the calmodulin genes, family members (parents, siblings and
      children) will also be asked to participate in the study. For under age patients and
      relatives who agree to participate, informed consent will also be taken from their custodian.
    
  